India’s Ebola Vaccine Push Highlights Growing Healthcare Role In Africa

The postponement of the fourth India-Africa Forum Summit amid concerns over the ongoing Ebola outbreak in parts of Africa has highlighted India’s expanding role in supporting the continent’s healthcare needs, according to a report by IOL.

India and the African Union deferred the summit, originally scheduled in New Delhi from May 28 to 31, after consultations on the evolving public health situation linked to the Bundibugyo Ebola virus outbreak reported in the Democratic Republic of Congo (DRC) and Uganda.

According to the report, the Serum Institute of India (SII) is collaborating with the Coalition for Epidemic Preparedness Innovations (CEPI) and Oxford University to accelerate the development of a vaccine targeting the Bundibugyo strain of Ebola. The report said this effort forms a key part of India’s contribution to the response.

The report noted that SII is using its ChAdOx1 vaccine platform, widely deployed during the Covid-19 pandemic, to fast-track the production of clinical-grade vaccine doses. These doses could be ready for trials within a few months.

The report also observed that India’s involvement mirrors its role during the Covid-19 crisis, when the country emerged as a major supplier of affordable vaccines to developing nations, including several African countries.

Beyond healthcare, the report highlighted India’s wider engagement with Africa through humanitarian assistance, including recent food aid initiatives for countries facing food insecurity and displacement challenges.

While the African Union and the Africa Centres for Disease Control and Prevention (Africa CDC) are leading the continent’s response to the Ebola outbreak, the report noted that vaccine research and large-scale manufacturing capacity continue to depend significantly on external partners.

The postponement of the summit has also underscored the need for greater investment in Africa’s biotechnology and vaccine manufacturing sectors to strengthen the continent’s long-term health security and preparedness for future outbreaks.